This paper is in the following e-collection/theme issue:

Research Letter (12) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1087) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1781) Early Results from COVID-19 Studies (335) Theme Issue 2022: Social Media, Ethics, and COVID-19 Misinformation (45)

Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50536, first published .
Exploring Public Sentiment on the Repurposing of Ivermectin for COVID-19 Treatment: Cross-Sectional Study Using Twitter Data

Exploring Public Sentiment on the Repurposing of Ivermectin for COVID-19 Treatment: Cross-Sectional Study Using Twitter Data

Exploring Public Sentiment on the Repurposing of Ivermectin for COVID-19 Treatment: Cross-Sectional Study Using Twitter Data

Authors of this article:

Angga Prawira Kautsar1, 2, 3 Author Orcid Image ;   Rano Kurnia Sinuraya1, 3, 4 Author Orcid Image ;   Jurjen van der Schans1, 5 Author Orcid Image ;   Maarten Jacobus Postma1, 3, 5 Author Orcid Image ;   Auliya A Suwantika3, 4, 6 Author Orcid Image
Article Authors Cited by Tweetations (1) Metrics
All Time | Last Month | Last Six Months | Last Year
@anggapk @anggapk @kautsar_ap

Twitter, now X, can serve as a data source for sentiment analysis on COVID-19 treatment candidates, Ivermectin. However, we must not overlook the importance of scientific evidence in medicine. Check out this fascinating article: https://t.co/1h5FbzxbV7

3:35 AM · Mar 29, 2025

0
0